February 23, 2017

Hodgkin Lymphoma: Intensifying Treatment With Rituximab After PET

Adjusting treatment dose after 2 courses of first-line therapy based on a positive PET scan does not improve progression-free survival (PFS) among patients with advanced stage Hodgkin lymphoma, according to a study published in The Lancet Oncology. {read more here}